Trial Profile
Phase II Study to Evaluate Efficacy and Safety of Capecitabine + Cisplatin Combination Therapy in Gastric Cancer Patients Who Relapsed After S-1 Adjuvant Chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms XParTS
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 26 Jul 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 26 Jul 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.